5 Biotech Stocks with Huge Potential

In this article, we will take a look at the 5 biotech stocks with huge potential. To read our analysis of the recent trends and market activity, you can go to the 10 Biotech Stocks with Huge Potential.

5. Incyte Corporation (NASDAQ:INCY)

Number of Hedge Fund Holders: 37

Wilmington, Delaware-based Incyte Corporation (NASDAQ:INCY) is global biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines across Oncology and Inflammation & Autoimmunity.

On February 27, Incyte Corporation (NASDAQ:INCY) announced that the FDA has granted priority review for axatilimab, an anti-CSF-1R antibody, for the treatment of chronic graft-versus-host disease (GVHD) after failure of at least two prior lines of systemic therapy.

Axatilimab is being developed by Incyte Corporation (NASDAQ:INCY) and Syndax Pharmaceuticals (NASDAQ:SNDX) as part of an exclusive worldwide co-development and co-commercialization license agreement.

As of Q4 2023, Incyte Corporation (NASDAQ:INCY) shares were held by 37 hedge funds with the total shares held by these hedge funds valued at $3.4 billion. Baker Bros. Advisors was the lead hedge fund shareholder with ownership of 36.2 million shares valued at $2.3 billion.